about
Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based ReviewTargeted Treatment in Childhood Epilepsy SyndromesDietary therapy is the best option for refractory nonsurgical epilepsyThe microRNA miR-124 suppresses seizure activity and regulates CREB1 activityP-gp Protein Expression and Transport Activity in Rodent Seizure Models and Human EpilepsyGabapentin: An update of its pharmacological properties and therapeutic use in epilepsyPerspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis.A candidate mechanism underlying the variance of interictal spike propagation.Atomic basis for therapeutic activation of neuronal potassium channels.Perampanel.Treatment options for refractory and difficult to treat seizures: focus on vigabatrinMechanism of action of vigabatrin: correcting misperceptions.Eslicarbazepine acetate for partial-onset seizures.Interactions between antiepileptics and second-generation antipsychotics.HCN and KV7 (M-) channels as targets for epilepsy treatment.Lacosamide for the treatment of partial-onset seizures.Enzyme induction with antiepileptic drugs: cause for concern?The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs.AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel.Phenotypic screens targeting neurodegenerative diseases.Novel approaches to anticonvulsant drug discovery.Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies.Pharmaceuticals and personal care products: A critical review of the impacts on fish reproduction.Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.Exploring the latest avenues for antiepileptic drug discovery and development.BGG492 as an adjunctive treatment in patients with partial-onset seizures: A 12-week, randomized, double-blind, placebo-controlled, phase II dose-titration study with an open-label extension.Proteomic Analysis After Status Epilepticus Identifies UCHL1 as Protective Against Hippocampal Injury.Optogenetic study of networks in epilepsy.Pharmacological Treatment of Drug-Resistant Epilepsy in Adults: a Practical Guide.Identifying new antiepileptic drugs through genomics-based drug repurposing.Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview.Clinical Experience With Perampanel for Refractory Pediatric Epilepsy in One Canadian Center.Recent Advances in Antiepileptic Herbal Medicine.MicroRNA-128 governs neuronal excitability and motor behavior in miceChronotolerance study of the antiepileptic drug valproic acid in miceNovel derivatives of phthalimide with potent anticonvulsant activity in PTZ and MES seizure models.Docking studies of phthalimide pharmacophore as a sodium channel blocker.Chronic application of topiramate and carbamazepine differentially affects the EEG and penicillin-induced epileptiform activity in rats.Fifty years of paediatric neurology in Australasia.Effects of midazolam and phenobarbital on brain oxidative reactions induced by pentylenetetrazole in a convulsion model.
P2860
Q26743786-2670B63C-5AF2-41C6-8108-EE0BD2E6FBE3Q26751431-8E783FEA-4D2F-456B-966D-7C0810D171CCQ26801202-0811C040-AF50-4806-A11F-942F17A5D863Q27693213-F5651C49-31E1-4025-A308-7D189D979D18Q33875127-24655229-2E3B-429C-BE96-408D614D334DQ35686045-D2AB555C-43BB-49DF-B4E2-B2C91D5E4BBBQ35761335-272C5BDF-EE8E-4D4A-BF2C-A4C8EA2E81CBQ35871186-281D0B4C-9A66-4FB9-BD45-4DA9F3178F52Q36033788-E6016D2C-7EC7-47D3-82A3-CD9A38D22222Q37339958-F6BD40B9-444C-412D-916F-AAFD9303D43EQ37937441-9E143600-F42B-4649-9A5C-EF316C38606AQ37953574-47ABFB46-DA5F-4939-B759-ED18E06C571CQ37957121-5F6B03F9-BC94-4570-AA75-00FB6BE8C467Q37983921-FA4F1FB5-9651-4E79-AFBC-C5E8ADB3EB14Q37996815-9EB7AF0A-85F5-4736-B98A-35C73C8BF03CQ38014885-E1D30160-DF67-4A35-9EBA-57E50B9A0DE9Q38046892-3194B959-ACAF-42D9-B036-487F395C97BDQ38104378-AA028E4B-23EE-46C2-B9F0-EE09BA10224CQ38112213-B6634857-4069-4336-88B1-CAC7B0D8B0C9Q38130052-2AFEF3E2-3725-4519-9F5A-2B3B44210F91Q38139499-8F70A0D4-59F9-41A8-BC13-224BC219ECD3Q38451680-FC1204B0-C277-4687-BD63-6F0D3FC64618Q38461963-FDF06D64-CA63-476F-BA61-E919D9CDA70EQ38746272-CCA89E68-4D1D-4B2A-8D64-40D39C8AEF89Q38754189-FBBAEDD0-FA65-43DC-8AB1-F2ED41A83287Q38788365-516E6472-7DF6-4351-9168-A2AFDDE1E3C7Q38843289-547856C4-43F5-40A2-9462-80C778111227Q38895992-4339BBBC-201D-48CF-9F93-7D762DB632D3Q38904679-AC873672-0285-4E58-B14D-2D3084626747Q39040011-B74CC507-55B2-41BF-AA42-1051AB4348E2Q39094490-B560B822-9FE5-4949-9E03-063FF565BFB6Q39311787-857B0358-550D-4039-855C-2D7CFC4C56F5Q40207224-58E9B4D3-0E36-481A-B492-DF987CA41A13Q41833350-2CFDFAB8-1B81-45A0-B2D7-0138F2522AB2Q42066350-E78ED677-275D-4846-A148-2D4FAB1FFFEFQ42071580-2CBD79EE-8EB6-4678-8A35-366E95AD6090Q42939077-10BD9516-831D-470C-AE5F-E26EFC503C01Q46165220-212855E9-8BEE-4BB5-96E4-CA8BA0DAE0A7Q47656158-EA8E0093-08F9-470B-BCB4-030EDC52D73EQ48237829-9696BBC0-0476-42DF-90CD-722D06AB2744
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Antiepileptic drug therapy the story so far.
@en
Antiepileptic drug therapy the story so far.
@nl
type
label
Antiepileptic drug therapy the story so far.
@en
Antiepileptic drug therapy the story so far.
@nl
prefLabel
Antiepileptic drug therapy the story so far.
@en
Antiepileptic drug therapy the story so far.
@nl
P1476
Antiepileptic drug therapy the story so far.
@en
P2093
Martin J Brodie
P304
P356
10.1016/J.SEIZURE.2010.10.027
P577
2010-11-12T00:00:00Z